Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy

Brain Res Mol Brain Res. 2004 Apr 29;124(1):70-8. doi: 10.1016/j.molbrainres.2004.02.010.

Abstract

Members of the ADAR (adenosine deaminases acting on RNA) gene family are involved in one type of RNA editing that converts adenosine residues to inosine. The A-to-I editing of serotonin receptor subtype 2C (5-HT(2C)R) mRNA leads to replacement of three amino acid residues located within the intracellular loop II domain, resulting in dramatic alterations in G-protein coupling functions of the receptor. It has been speculated that RNA editing may play a role in several pharmacological and behavioral processes where the serotonergic plasticity is mediated through 5-HT(2C)R. Interferon-alpha (IFN-alpha) often causes severe depression in patients treated for chronic viral hepatitis and certain malignancies. In this study, we examined the effects of IFN-alpha on RNA editing in human glioblastoma cell lines, which express 5-HT(2C)R mRNAs. ADAR1 expression and the pattern of the 5-HT(2C)R mRNA editing rapidly changed in response to IFN-alpha, leading to the dominant expression of the 5-HT(2C)R-VSI isoform predicted to have reduced G-protein coupling functions. Our results support the hypothesis that 5-HT(2C)R mRNA editing has causative relevance in the pathophysiology of depression associated with cytokine therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Deaminase / metabolism
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Blotting, Western / methods
  • Cell Line, Tumor
  • Cytokines / therapeutic use
  • Depression / chemically induced
  • Gene Expression Regulation / drug effects
  • Glioblastoma
  • Humans
  • Interferons / adverse effects
  • Interferons / pharmacology*
  • Models, Genetic
  • RNA Editing / drug effects*
  • RNA, Messenger / metabolism
  • RNA-Binding Proteins
  • Receptor, Serotonin, 5-HT2C / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Time Factors

Substances

  • Antineoplastic Agents
  • Cytokines
  • RNA, Messenger
  • RNA-Binding Proteins
  • Receptor, Serotonin, 5-HT2C
  • Interferons
  • ADARB1 protein, human
  • Adenosine Deaminase